BioSET uses bioactive peptides in order to communicate growth signals to damaged cells, which promotes the healing process.
Tornier will use the technology to emphasize treatment on rotator cuff, shoulder, knee, and elbow injuries. The company is working to develop a soft-tissue graft with synthetic human growth factor.
Read the R&D report on this tissue repair technology.
Read more coverage on tissue repair:
– Anulex Technologies Raises $2M for Soft Tissue Repair Product Development
– KFx Medical Receives 510(k) Clearance for Arthroscopic Knee Products
– Smith & Nephew Introduce TWINFIX Suture Anchor for Rotator Cuff Repair
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
